Stay updated on ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a site/version change rather than a modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T05:25:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A minor software revision was applied, updating the page revision from v3.5.0 to v3.5.2. This change does not affect the study data, eligibility criteria, or core content on the page.
    Difference
    0.0%
    Check dated 2026-04-18T03:50:32.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Primary Completion Date updated to 2026-12-23 and a new Last Update entry on 2026-04-07 were added. Several older date entries (e.g., 2026-02xx and 2026-04-23) were removed.
    Difference
    0.2%
    Check dated 2026-04-10T22:15:34.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T07:22:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:37:19.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied, adding USWM CT, LLC and USWM, LLC (dba US WorldMeds) as sponsors/collaborators. Prior collaborators and IPD sharing plan references were removed.
    Difference
    0.8%
    Check dated 2026-02-12T02:25:39.000Z thumbnail image

Stay in the know with updates to ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.